TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.

Avia D Wilkerson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.